Pharmaceutics (Dec 2022)

Extract of Calyces from <i>Physalis peruviana</i> Reduces Insulin Resistance and Oxidative Stress in Streptozotocin-Induced Diabetic Mice

  • Ivonne Helena Valderrama,
  • Sandra Milena Echeverry,
  • Diana Patricia Rey,
  • Ingrid Andrea Rodríguez,
  • Fátima Regina Mena Barreto Silva,
  • Geison M. Costa,
  • Luis Fernando Ospina-Giraldo,
  • Diana Marcela Aragón

DOI
https://doi.org/10.3390/pharmaceutics14122758
Journal volume & issue
Vol. 14, no. 12
p. 2758

Abstract

Read online

Diabetes mellitus is a metabolic disorder mainly characterized by obesity, hyperglycemia, altered lipid profile, oxidative stress, and vascular compromise. Physalis peruviana is a plant used in traditional Colombian medicine for its known activities of glucose regulation. This study aimed to evaluate the anti-diabetic activity of the butanol fraction from an extract of Physalis peruviana calyces in two doses (50 mg/kg and 100 mg/kg) in induced type 2 diabetic mice. Blood glucose levels were evaluated once a week, demonstrating that a dose of 100 mg/kg resulted in greater regulation of blood glucose levels in mice throughout the experiment. The same overall result was found for the oral glucose tolerance test (OGTT) and the homeostatic model assessment for insulin resistance (HOMA- IR). The lipid profile exhibited improvement compared to the non-treated group, a dose of 100 mg/kg having greater protection against oxidative stress (catalase, superoxide dismutase, and malondialdehyde levels). Histopathological findings in several tissues showed structure preservation in most of the animals treated. The butanol fraction from Physalis peruviana at 100 mg/kg showed beneficial results in improving hyperglycemia, lipidemia, and oxidative stress status, and can therefore be considered a beneficial coadjuvant in the therapy of diabetes mellitus.

Keywords